Company Profile
Genomic Vision is a molecular diagnostics and technology company specialized in the development of single DNA detection tools for research and in vitro diagnostics
News
14/12/2015
Genomic Vision and Reims University Hospital Launch Clinical Study to Establish New Screening Tool for Early Detection and Prevention of Cervical Cancer
03/12/2015
Genomic Vision signs a strategic partnership with the Imagine Institute, the largest European genetic research and care cluster
15/10/2015
GENOMIC VISION and ROUEN University Hospital launch a trial to improve genetic counseling for Infantile Spinal Muscular Atrophy in France
09/06/2015
Genomic Vision selected for the Horizon 2020 program’s ‘BeyondSeq’ project with a total grant of €6 million
15/03/2015
Financial information at March 31, 2015
15/03/2015
FYR 2014 in line with the Company's buoyant development
Total revenue from activity: €4.9 million
Operating costs under control
Solid cash position of €22.8 million
17/02/2015
Genomic Vision renews its Strategic Collaboration with Quest Diagnostics for three more years
09/02/2015
Financial Agenda 2015
15/01/2015
2014 Annual Revenue from Sales at €3.5 Million
07/01/2015
Genomic Vision achieves major milestone with delivery of new high-throughput genome analyzer to Quest Diagnostics
